The Distribution of Fetal Nuchal Translucency Thickness in Normal Korean Fetuses

Journal of Korean Medical Science

Volumn 19, Issue 1, 2004, Pages 32-36

  Chung, Jin Hoon ^a   Yang, Jae Hyug ^a   Song, Mi Jin ^a   Cho, Jeong Yeon ^a   Lee, Young Ho ^a   Park, So Yeon ^a   Moon, Myoung Jin ^a   Lim, Ha Jung ^a   Choi, June Seek ^a   Kim, Joo Oh ^a   Shin, Joong Sik ^a   Ahn, Hyun Kyong ^a   Han, Jung Yul ^a   Kim, Moon Young ^a   Choi, Kyu Hong ^a   Ryu, Hyun Mee ^a,b  

^a Sungkyunkwan University   (South Korea)

^b Samsung Advanced Institute of Technology (SAIT)   (South Korea)

Author keywords

Crown rump length; Nuchal translucency; Pregnancy trimester, first; Ultrasonography

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CROWN RUMP LENGTH; ERROR; FEMALE; FETUS; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; KOREA; LINEAR REGRESSION ANALYSIS; NORMAL HUMAN; PREGNANCY; SCREENING TEST; THICKNESS;

EID: 10744221755     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2004.19.1.32     Document Type: Article

References (28)

1. Nicolaides KH, Brizot ML, Snijders RJ. Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy. Br J Obstet Gynaecol 1994; 101: 782-6.
2. Pandya PP, Snijders RJ, Johnson SP, De Lourdes Brizot M, Nicolaides KH. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 1995; 102: 957-62.
3. Pandya PP, Kondylios A, Hilbert L, Snijders RJ, Nicolaides KH. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 1995; 5: 15-9.
4. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. Br Med J 1999; 318: 81-5.
5. Hafner E, Schuchter K, Liebhart E, Philipp K. Results of routine fetal nuchal translucency measurement at weeks 10-13 in 4233 unselected pregnant women. Prenat Diagn 1998; 18: 29-34.
6. Spencer K, Spencer CE, Power M, Moakes A, Nicolaides KH. One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. Br J Obstet Gynaecol 2000; 107: 1271-5.
7. Watt HC, Wald NJ, Smith D, Kennard A, Densem J. Effect of allowing for ethnic group in prenatal screening for Down's syndrome. Prenat Diagn 1996; 16: 691-8.
8. Spencer K, Ong CY, Liao AW, Nicolaides KH. The influence of ethnic origin on first trimester biochemical markers of chromosomal abnormalities. Prenat Diagn 2000; 20: 491-4.
9. Thilaganathan B, Khare M, Williams B, Wathen NC. Influence of ethnic origin on nuchal translucency screening for Down's syndrome. Ultrasound Obstet Gynecol 1998; 12: 112-4.
10. Park JW, Lee WK. Changes of nuchal translucency in early normal fetuses. Korean J Obstet Gynecol 2000; 43: 998-1001.
11. Lee K, Cha DH, Park SP, Park HJ. Nuchal translucency measurement in normal fetuses at 10-14 weeks of gestation I. Korean J Obstet Gynecol 2000; 43: 1822-7.
12. Lee K, Cha DH, Kim JH, Seo SK, Lee DW, Cho SH, Kwon JY. Nuchal translucency measurement in normal Korean fetuses at 10-14 weeks of gestation (II). Korean J Obstet Gynecol 2003; 46: 522-7.
13. Hadlock FP, Shah YP, Kanon DJ, Lindsey JV. Fetal crown-rump length: Reevaluation of relation to menstrual age (5-18 weeks) with high-resolutin real-time US. Radiology 1992; 182: 501-5.
14. Ville Y, Lalondrelle C, Doumerc S, Daffos F, Frydman R, Oury JF, Dumez Y. First trimester diagnosis of nuchal anomalies: significance and fetal outcome. Ultrasound Obstet Gynecol 1992; 2: 314-6.
15. Whitlow BJ, Chatzipapas IK, Economides DL. The effect of fetal neck position on nuchal translucency measurement. Br J Obstet Gynecol 1998; 105: 872-6.
16. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 1998; 352: 343-6.
17. Scott F, Boogert A, Sinosich M, Anderson J. Establishment and application of a normal range for nuchal translucency across the first trimester. Prenat Diagn 1996; 16: 629-34.
18. Taipale P, Hiilesmaa V, Salonen R, Ylostalo P. Increased nuchal translucency as a marker for fetal chromosomal defects. N Eng J Med 1997; 337: 1654-8.
19. Schuchter K, Wald N, Hackshaw AK, Hafner E, Liebhart E. The distribution of nuchal translucency at 10-13 weeks of pregnancy. Prenat Diagn 1998; 18: 281-6.
20. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, Haddow JE, Knight GJ, Palomaki GE, Canick JA. Maternal serum screening for Down's syndrome in early pregnancy. Br Med J 1988; 297: 883-7.
21. Snijders PJ, Johnson S, Sebire NJ, Noble PL, Nicolaides KH. First-trimester ultrasound screening for chromosomal defects. Ultrasound Obstet Gynecol 1996; 7: 216-26.
22. Kim MY, Ryu HM, Kim ES, Han HW, Yang JH, Yoo SJ, Lee YH, Han JR, Lee KS. The value of increased nuchal translucency (NT) for the prediction of abnormal pregnancy outcome. Korean J Perinatol 1998; 9: 363-74.
23. Lee JY, Choi KH, Park CW, Yun TS, Park CJ, Jang PR, Park YS. Fetal nuchal translucency measurement for detection of chromosomal abnormalities in the first trimester of high risk pregnancy. Korean J Obstet Gynecol 1998; 41: 2739-42.
24. Kim SJ, Kim CM, Min BS, Sohn WS, Kang JB, Jang PR. The efficacy of nuchal translucency with free beta-hCG, PAPP-A as a screening test for detection of chromosomal anomaly in the first trimester of pregnancy. Korean J Obstet Gynecol 2001; 44: 1091-6.
25. Jou HJ, Wu SC, Li TC, Hsu HC, Tzeng CY, Hsieh FJ. Relationship between fetal nuchal translucency and crown-rump length in an Asian population. Ultrasound Obstet Gynecol 2001; 17: 111-4.
26. Chen M, Lam YH, Tang MH, Lee CP, Sin SY, Tang R, Wong HS, Wong SF. The effect of ethnic origin on nuchal translucency at 10-14 weeks of gestation. Prenat Diagn 2002; 22: 576-8.
27. Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides K. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet 2001; 358: 1665-7.
28. Cicero S, Bindra R, Rembouskos G, Spencer K, Nicolaides KH. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free β-hCG and PAPP-A at 11 to 14 weeks. Prenat Diagn 2003; 23: 306-10.